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Abstract 
Background: To determine the frequency and 
types  of blood transfusion reactions during 
pregnancy. 
Methods: In this descriptive study 1754 
consecutive pregnant women during a period of 
twelve months, were included. All reactions were 
reported to the blood bank.  Frequency of blood 
transfusion reactions, type of transfusion reactions, 
morbidity, complication or mortality was noted.  
Results: Out of total cases of anaemia (1754), the 
patients having blood transfusions were 26.6% 
(n=468). Out of 468 post transfusion reactions were 
observed in 20.9%. Transfusion reactions were 
categorized as hemolytic reactions in 4.9% , 
nonhemolytic reactions in 4.2% and febrile reactions 
in 11.7%. Out of 98 cases of blood transfusion 
reactions two cases expired due to severe hemolytic 
reaction . 
Conclusion: Blood transfusion for the treatment of 
anaemia should be reserved only for 
hemodynamically unstable patients or any other co 
morbidity during pregnancy. 
Key Words: Transfusion reactions, Hemolytic 
reactions, febrile reactions 
 
Introduction 
           Pregnancy is a physiological phenomenon but 
needs careful antenatal care to have healthy 
fetomaternal outcome. Treatment of anaemia, during 
pregnancy, depends on the type, severity of anemia 
and gestation at which anemia is diagnosed. Severe 
(Hb <7g/dl) anemia at any gestation is managed with 
blood transfusion in second half of pregnancy.1 
Obstetric haemorrhage is another indication of blood 
transfusion in pregnancy or labour. Obstetric 
hemorrhage is a common cause of maternal death, 
causing 24% of, or an estimated 127,000, maternal 
deaths annually 1. It has also been reported that 
massive (2,000  mL or more) and life-threatening 
obstetric hemorrhage occurs in 3–5%  and 0.1% of 
deliveries, respectively, and blood product transfusion 
is required in 0.3–1%. 2-6   
     Normal pregnancy is characterized by increased 
complement components in maternal circulation8. 
Indeed, higher plasma anaphylatoxins concentrations 
are found during normal pregnancy compared to non-
pregnant women. As part of innate immunity, 
complement system participates in recognition and 
elimination of microorganism and foreign cells and in 
the inflammatory response. It also constitutes a bridge 
between innate and adaptive immunity.7-10 
     Blood transfusions sometimes cause acute 
transfusion reactions(ATR). The frequency of ATRs is 
estimated to be 0.2% to 10% and are responsible for 
death in approximately 1 per 250,000.11 Transfusion 
reactions may be hemolytic, nonhemolytic or febrile 
reactions Nonhemolytic fever reactions cause fever 
and chills without destruction (hemolysis) of the red 
blood cells. This is the most common transfusion 
reaction. It can occur even when the blood has been 
correctly matched and administered. 11-13 
     Hemolytic transfusion reactions (HTRs) are 
reactions in which donor RBCs are destroyed by 
antibodies in the recipient's circulation. They occur 
when antigen-positive donor RBCs are transfused into 
a patient who has preformed antibodies to that 
antigen. The donor RBCs may be destroyed 
immediately (a potentially serious reaction) or may 
have a shortened or even normal survival time (milder 
reactions).  Most of the time, these reactions to the 
minor blood types are less serious than a mismatch of 
the ABO or Rh blood types. Rh blood group is a 
complex blood group systems. The complexity of the 
Rh blood group antigens begins with the highly 
polymorphic genes that encode them. To date, 49 Rh 
antigens are known. The most significant antigens are 
D,C,E ,c, e . These antigens are involved in antigen 
antibody reactions on blood transfusion. An immune 
reaction to platelets in transfused blood results in the 
destruction of the transfused platelets. In rare cases, an 
immune reaction may take place that attacks the 
person's lungs causing TRALI (transfusion-related 
acute lung injury).This is believed to be caused by 
recipient’s white blood cells being attacked by donor’s 
white blood or plasma cells. This results in dyspnea 
and other symptoms. Most people recover fully from 
this type of reaction. Fluid overload is a common type 
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of nonimmune reaction. 14.15 Blood transfusion can be 
life-saving and provides great clinical benefit to many 
patients but it is not without risks:11Errors and 'wrong 
blood' episodes (UK data from Serious Hazards of 
Transfusion(SHOT)) suggests an error incidence of 
11.4/100,000 components transfused).12 
 
Patients and Methods 
   The study involved 1754 consecutive pregnant 
women during a period of twelve months who 
received blood transfusion in the Department of 
Obstetrics and Gynaecology,DHQ Teaching Hospital, 
Rawalpindi. Data was collected by a structured 
proforma from patients who had transfusion reaction. 
Demographic details of patients were taken. The 
symptoms on transfusion reaction were noted and 
categorized as haemolytic, non haemolytic and febrile 
reactions. Every patient who had transfusion reaction, 
blood sample was taken for re-cross match, Coombs’ 
(direct) test and urine sample was taken for 
methemoglobinuria.Patients were given symptomatic 
treatment for the reaction like antihistamine and 
steroids. All patients were kept in HDU (high 
dependency unit).All reactions were reported to the 
blood bank unit at DHQ Hospital. Frequency of blood 
transfusion reactions, type of transfusion reactions, 
morbidity, complication or mortality was noted. 
 
Results 
    Out of total cases of anaemia (1754), the patients 
having blood transfusions were 26.6% (n=468) . 
Patients having post transfusion reactions were 20.9% 
(n=98) while 79.05% had no transfusion reactions 
.Transfusion reactions were catagorized as hemolytic 
reactions 4.9%(n=23) , nonhemolytic reactions 
4.2%(n=20) and febrile reactions 11.7%(n=55). Among 
the non hemolytic reactions 60% (n=12) cases had 
rashes while 30%(n=6) had shortness of breath and 
10%(n=2) had hypotension. Two maternal mortalities 
were observed due to severe haemolytic reaction 
(Table 1) 
Discussion 
     Advances in the field of transfusion medicine have 
revolutionized modern medicine. Gynaecology and 
Obstetrics departments in every health care facility are 
one of the prime consumers of blood components. 
Blood is required to combat the adverse events, a 
possible likelihood if haemoglobin is less than the 
desired limits and if there are haemorrhagic  
incidences .Safe transfusion practices have strong 
impact on surgical, gynaecological and chronic patient  
Table 1: Blood transfusion reactions during 
pregnancy 468/1754) (26.6%) 
Type of reaction No (%) 
Haemolytic 23(4.9) 
Non Haemolytic Transfusion 
Reactions  
          Rashes    
         Dyspnoea 
         Hypotension                 
20(4.2) 
 
12(2.5) 
6(1.3) 
2(0.4) 
Febrile Reactions 55(11.7) 
No reactions 370(79.05) 
Two maternal mortalities were observed due to 
severe haemolytic reaction 
 
care. On one hand maternal morbidity and even 
mortality depends on availability of blood and blood 
products and on the other hand injudicious use of 
blood and blood products can cause infection, allergic 
reaction or antibody production in the mother which 
can have major impact on the present or future 
pregnancies. 14-19 
     Different studies reported transfusion associated 
reactions ranging from 6.6% to 14.4%. In present study 
the frequency is higher as compared to the other 
studies .Though blood transfusion was given under 
strict monitoring on a predesigned proforma. A very 
high percentage of transfusion reactions can be 
attributed to several factors. It can be because of blood 
transfusion in a high risk group as the patients are 
pregnant. This may be attributed to some lapse at 
pretransfusion screening and cross matching step. 
Furthermore transfusion reactions were commonly 
observed during summer season which might be due 
to inadequate temperature controls for storage of 
donor’s blood. We obsereved transfusion reactions in 
20.9% patients in comparison to a study at Toronto 
(Canada) where it was 10%. The error incidence was 
11.4/100,000 components transfused in a study done 
in United Kingdom (SHOT study)12. The error 
incidence was 570/10,000 transfusions (10 cases out of 
1754 transfusions) in our study where it was 
hematologically proven by positive Coombs’ test or 
methemoglobinuria. Two of our patients died 
unfortunately due to haemolytic transfusion reactions 
leading to acute renal failure and disseminated 
intravascular coagulation over a period of one year. In 
comparison 92 deaths have been reported to french 
hemovigilance system(1992-97). Over the first 11 years 
of reporting (1996-2007), 115 deaths reported to the 
United Kingdom Serious Hazards of Transfusion 
(SHOT) surveillance system due to transfusion 
reactions. In a national study no mortality was 
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observed which must be due to accurate compatibility, 
cross matching and screening facilities. 19 Different 
Pakistani studies report blood transfusion reactions 
from 5-12%.20-22 A high rate of 20.9%, reported in 
present study, with two mortalities, reflects 
inadequacies, thereby needing serious contemplations.  
 
Conclusion 
1. Blood transfusion for the treatment of anaemia 
should be reserved only for hemodynamically 
unstable patients or any other co morbidity during 
pregnancy. 
2. Blood bank providing the transfusion should have 
adequate cross matching and storage facilities to 
yield favourable results with negligible reactions.  
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